{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:42:24Z","timestamp":1789353744853,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.06.047","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T03:42:49Z","timestamp":1434598969000},"page":"3953-3962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["ISCOMATRIX\u2122 adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans"],"prefix":"10.1016","volume":"33","author":[{"given":"Ka Yan","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewal","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukmini","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gale","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.06.047_bib0195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1126\/science.1240532","article-title":"H7N9 influenza viruses are transmissible in ferrets by respiratory droplet","volume":"341","author":"Zhang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.1239844","article-title":"Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs","volume":"341","author":"Zhu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0205","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1242917","article-title":"Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses","volume":"342","author":"Shi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0215","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nature12372","article-title":"Receptor binding by an H7N9 influenza virus from humans","volume":"499","author":"Xiong","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0220","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","author":"Watanabe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0225","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/JVI.00894-14","article-title":"Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission","volume":"88","author":"Liu","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0230","doi-asserted-by":"crossref","first-page":"185ra68","DOI":"10.1126\/scitranslmed.3006368","article-title":"Synthetic generation of influenza vaccine viruses for rapid response to pandemics","volume":"5","author":"Dormitzer","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0235","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0240","doi-asserted-by":"crossref","first-page":"234ra55","DOI":"10.1126\/scitranslmed.3008761","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0245","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0250","doi-asserted-by":"crossref","first-page":"e49704","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"Couch","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0255","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0260","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/icb.2009.21","article-title":"Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant","volume":"87","author":"Maraskovsky","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0265","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4049\/jimmunol.182.3.1253","article-title":"ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II","volume":"182","author":"Schnurr","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0270","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/icb.2011.71","article-title":"ISCOMATRIX vaccines mediate CD8+T-cell cross-priming by a MyD88-dependent signaling pathway","volume":"90","author":"Wilson","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0275","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.4049\/jimmunol.1302011","article-title":"Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant","volume":"192","author":"Wilson","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0280","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1099\/jmm.0.040857-0","article-title":"ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases","volume":"61","author":"Morelli","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0285","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.vaccine.2015.03.009","article-title":"Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0290","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0295","doi-asserted-by":"crossref","first-page":"e1000049","DOI":"10.1371\/journal.pmed.1000049","article-title":"Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets","volume":"6","author":"Khurana","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0300","doi-asserted-by":"crossref","first-page":"15ra5","DOI":"10.1126\/scitranslmed.3000624","article-title":"Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus","volume":"2","author":"Khurana","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0305","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0310","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1128\/JVI.05406-11","article-title":"H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans","volume":"85","author":"Khurana","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0315","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0320","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1016\/j.vaccine.2014.09.049","article-title":"H5 N-terminal beta sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine","volume":"32","author":"Khurana","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0325","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jir791","article-title":"Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender","volume":"205","author":"Khurana","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0330","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/jit178","article-title":"DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults","volume":"208","author":"Khurana","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0335","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2013.6589","article-title":"Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9)","volume":"309","author":"Osterholm","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0340","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0345","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/j.vaccine.2007.02.059","article-title":"Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza","volume":"25","author":"Pushko","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0350","doi-asserted-by":"crossref","first-page":"e1501","DOI":"10.1371\/journal.pone.0001501","article-title":"Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle","volume":"3","author":"Bright","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0355","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv210","article-title":"High-affinity H7 head and stalk domain-specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine","author":"Halliley","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0360","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0365","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.2014.12609","article-title":"Immunogenicity of avian influenza A\/Anhui\/01\/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Belshe","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0370","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1073\/pnas.0403572101","article-title":"Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans","volume":"101","author":"Davis","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0375","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.addr.2004.09.006","article-title":"ISCOMATRIX adjuvant for antigen delivery","volume":"57","author":"Pearse","year":"2005","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.vaccine.2015.06.047_bib0380","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1128\/JVI.02743-07","volume":"82","author":"Lin","year":"2008","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15008361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15008361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T18:18:12Z","timestamp":1599157092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15008361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":38,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15008361"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ISCOMATRIX\u2122 adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}